Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease

Rossi, S. H. et al. (2013) Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease. BMC Nephrology, 14(173), (doi: 10.1186/1471-2369-14-173)

[img]
Preview
Text
84584.pdf - Published Version
Available under License Creative Commons Attribution.

951kB

Publisher's URL: http://dx.doi.org/10.1186/1471-2369-14-173

Abstract

<p>Background Chronic kidney disease (CKD) and coronary artery disease (CAD) are independently associated with increased vascular stiffness. We examined whether renal function contributes to vascular stiffness independently of CAD status.</p> <p>Methods We studied 160 patients with CAD and 169 subjects without CAD. The 4-variable MDRD formula was used to estimate glomerular filtration rate (eGFR); impaired renal function was defined as eGFR <60 mL/min. Carotid-femoral pulse wave velocity (PWV) was measured with the SphygmoCor® device. Circulating biomarkers were assessed in plasma using xMAP® multiplexing technology.</p> <p>Results Patients with CAD and impaired renal function had greater PWV compared to those with CAD and normal renal function (10.2 [9.1;11.2] vs 7.3 [6.9;7.7] m/s; P < 0.001). In all patients, PWV was a function of eGFR (β = −0.293; P< 0.001) even after adjustment for age, sex, systolic blood pressure, body mass index and presence or absence of CAD. Patients with CAD and impaired renal function had higher levels of adhesion and inflammatory molecules including E-selectin and osteopontin (all P< 0.05) compared to those with CAD alone, but had similar levels of markers of oxidative stress.</p> <p>Conclusions Renal function is a determinant of vascular stiffness even in patients with severe atherosclerotic disease. This was paralleled by differences in markers of cell adhesion and inflammation. Increased vascular stiffness may therefore be linked to inflammatory remodeling of the vasculature in people with impaired renal function, irrespective of concomitant atherosclerotic disease.</p>

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Taurino, Dr Chiara and McQuarrie, Dr Emily and Dymott, Dr Jane and Miller, Dr Ashley and Moreno Zulategui, Dr Maria de Ujue and Neisius, Dr Ulf and Rossi, Miss Sabrina and Dominiczak, Professor Anna and Delles, Professor Christian and MacKenzie, Dr Ruth and Miller, Dr William
Authors: Rossi, S. H., McQuarrie, E. P., Miller, W. H., MacKenzie, R. M., Dymott, J. A., Moreno, M. U., Taurino, C., Miller, A. M., Neisius, U., Berg, G. A., Valuckiene, Z., Hannay, J. A., Dominiczak, A. F., and Delles, C.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:BMC Nephrology
Publisher:BioMed Central
ISSN:1471-2369
ISSN (Online):1471-2369
Copyright Holders:Copyright © 2013 The Authors
First Published:First published in BMC Nephrology 14(173)
Publisher Policy:Reproduced under a Creative Commons License
Related URLs:

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
483611Interleukin-33: A Novel Cytokine in the Inflammation of Atherosclerosis and ObesityAshley MillerBritish Heart Foundation (BHF)FS/08/035/25309III -IMMUNOLOGY
483612Interleukin-33: A Novel Cytokine in the Inflammation of Atherosclerosis and ObesityAshley MillerBritish Heart Foundation (BHF)FS/08/035/25309III -IMMUNOLOGY